Can a Two-Drug combo outsmart advanced cancers?
Disease control
Completed
This trial is testing whether adding an experimental drug called HBI-8000 to the immunotherapy nivolumab can safely control advanced melanoma, kidney cancer, and non-small cell lung cancer. The study enrolls adults whose cancers have not responded to prior treatments. Researchers…
Phase: PHASE1, PHASE2 • Sponsor: HUYABIO International, LLC. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC